Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: A role for PPAR-γ pathway

Atherosclerosis

Volumn 208, Issue 1, 2010, Pages 119-125

  Khateeb, Jasmin ^a   Gantman, Anna ^a   Kreitenberg, Adam J ^a   Aviram, Michael ^a   Fuhrman, Bianca ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antioxidants; Paraoxonase 1 (PON1); Polyphenols; Pomegranate

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ELLAGIC ACID; GALLIC ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYPHENOL DERIVATIVE; POMEGRANATE EXTRACT; PUNICALAGIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME RELEASE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIPID OXIDATION; LIVER CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ARYLDIALKYLPHOSPHATASE; CELLS, CULTURED; ELLAGIC ACID; GALLIC ACID; HEPATOCYTES; HUMANS; HYDROLYZABLE TANNINS; PPAR GAMMA; PUNICACEAE; UP-REGULATION;

EID: 73449098892     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.08.051     Document Type: Article

References (28)

1. Deakin S., Leviev I., Gomaraschi M., et al. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem 277 (2002) 4301-4308
2. Aviram M., Kaplan M., Rosenblat M., and Fuhrman B. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol 170 (2005) 263-300
3. Aviram M., Rosenblat M., Bisgaier C.L., et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101 (1998) 1581-1590
4. Rozenberg O., Shih D.M., and Aviram M. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis 181 (2005) 9-18
5. Aviram M., Rosenblat M., Billecke S., et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26 (1999) 892-904
6. Rozenberg O., Rosenblat M., Coleman R., Shih D.M., and Aviram M. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med 34 (2003) 774-784
7. van der Gaag M.S., van Tol A., Scheek L.M., et al. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis 147 (1999) 405-410
8. Jarvik G.P., Tsai N.T., McKinstry L.A., et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 22 (2002) 1329-1333
9. Fuhrman B., and Aviram M. Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation. Ann N Y Acad Sci 957 (2002) 321-324
10. Aviram M., Dornfeld L., Rosenblat M., et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71 (2000) 1062-1076
11. Feingold K.R., Memon R.A., Moser A.H., and Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139 (1998) 307-315
12. Deakin S., Leviev I., Guernier S., and James R.W. Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2. Arterioscler Thromb Vasc Biol 23 (2003) 2083-2089
13. Gouédard C., Barouki R., and Morel Y. Induction of the paraoxonase-1 gene expression by resveratrol. Arterioscler Thromb Vasc Biol 24 (2004) 2378-2383
14. Gong M., Garige M., Varatharajalu R., et al. Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation. Biochem Biophys Res Commun 379 (2009) 1001-1004
15. Gouédard C., Barouki R., and Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 24 (2004) 5209-5222
16. Osaki F., Ikeda Y., Suehiro T., et al. Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells. Atherosclerosis 176 (2004) 279-287
17. Arii K., Suehiro T., Ota K., et al. Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells. Atherosclerosis 202 (2009) 439-445
18. Aviram M., Dornfeld L., Kaplan M., et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res 28 (2002) 49-62
19. Aviram M., Volkova N., Coleman R., et al. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins. J Agric Food Chem 56 (2008) 1148-1157
20. Xia M., Hou M., Zhu H., et al. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway. J Biol Chem 280 (2005) 36792-36801
21. Huang T.H., Peng G., Kota B.P., et al. Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component. Toxicol Appl Pharmacol 207 (2005) 160-169
22. Gouédard C., Koum-Besson N., Barouki R., and Morel Y. Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins. Mol Pharmacol 63 (2003) 945-956
23. Shiner M., Fuhrman B., and Aviram M. Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation. Atherosclerosis 195 (2007) 313-321
24. Burgermeister E., Chuderland D., Hanoch T., et al. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol 27 (2007) 803-817
25. Burns K.A., and Vanden Heuvel J.P. Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta 1771 (2007) 952-960
26. Lazennec G., Canaple L., Saugy D., and Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol 14 (2000) 1962-1975
27. Li Y., Qi Y., Huang T.H., Yamahara J., and Roufogalis B.D. Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties. Diabetes Obes Metab 10 (2008) 10-17
28. Virgili F., and Marino M. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med 45 (2008) 1205-1216